Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ZYDUSLIFE.NSthis companyZydus Lifesciences Limited	₹1,215.90	17.39×	3.23×	3.23×	11.53×	57.8%	51.7%	21.3%	18.6%	18.6%	9.7%	-1.4%	0.46×	1.29×	13.18×	1.27×	1.3%	4	—	2	B-
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
ALKEM.NSAlkem Laboratories Limited	₹5,398.50	27.24×	4.54×	4.26×	18.9×	35.0%	65.4%	17.8%	15.6%	16.7%	12.5%	2.1%	0.15×	0.53×	16.32×	2.55×	1.0%	3	—	2	B-
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
FDC.NSFDC Limited	₹394.20	18.57×	2.1×	2.41×	11.83×	14.1%	42.3%	13.2%	13.0%	11.3%	8.4%	1.2%	0.01×	-0.08×	57.54×	3.11×	1.6%	3	8.69	4	A
Peer median	—	24.38×	2.87×	3.51×	14.44×	25.1%	44.6%	16.7%	13.8%	11.4%	9.8%	2.2%	0.02×	0.07×	57.54×	3.11×	1.0%	4	8.69	4	—